ZeroStack (ZSTK) Stock Overview
Through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ZSTK Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
ZeroStack Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.65 |
| 52 Week High | US$47.00 |
| 52 Week Low | US$3.72 |
| Beta | 1.78 |
| 1 Month Change | 0% |
| 3 Month Change | -33.62% |
| 1 Year Change | -84.69% |
| 3 Year Change | -96.41% |
| 5 Year Change | -99.83% |
| Change since IPO | -99.88% |
Recent News & Updates
Narrative Update • Feb 19
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.Narrative Update • Feb 05
ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.Recent updates
Narrative Update • Feb 19
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.Narrative Update • Feb 05
ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.Narrative Update • Jan 22
FLGC: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Flora Growth from $20.50 to $11.00, citing updated assumptions that now reflect a steeper projected revenue decline of 24.87% along with a slightly lower discount rate and essentially unchanged profit margin and future P/E inputs. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp.Analysis Article • Jan 13
Flora Growth Corp. (NASDAQ:FLGC) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 26% in the...Narrative Update • Jan 07
FLGC: Forward Share Split And Preferred Share Authorization Will Drive Upside
Analysts now place their price target for Flora Growth at US$20.50, unchanged from the prior US$20.50. They cite only marginal tweaks to inputs, such as a slightly lower discount rate, while keeping revenue growth and profit margin expectations effectively stable.Narrative Update • Dec 24
FLGC: Forward Share Split And Preferred Shares Will Support Upside Potential
Analysts have modestly raised their price target on Flora Growth, increasing the estimate by $0.00 to reflect a slightly higher perceived risk profile driven by an uptick in the discount rate, while keeping long term growth and profitability expectations essentially unchanged. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp., create a new class of preferred shares, and implement a forward share split of between 2:1 and 10:1.Narrative Update • Dec 10
FLGC: Forward Share Split And New Capital Raising Will Fuel Upside Potential
Analysts have modestly raised their price target on Flora Growth to $20.50, citing a slightly lower perceived risk reflected in a reduced discount rate, while maintaining stable expectations for revenue growth and profit margins. What's in the News Flora Growth has convened a special shareholders meeting for December 19, 2025 in Toronto to vote on corporate actions including capital structure and governance items (company filing).Narrative Update • Nov 25
FLGC: Forward Share Split and Equity Offering Will Drive Renewed Momentum
Analysts have significantly lowered their price target for Flora Growth from $93.00 to $20.50. They cite revised expectations for revenue growth and a slightly reduced discount rate as key factors influencing this adjustment.Analysis Article • Sep 09
Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 26% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...Narrative Update • Aug 19
US Cannabis And European Beverage Markets Will Create Opportunities
Flora Growth’s consensus Analyst Price Target was notably reduced from $156.00 to $93.00 due to continued gross margin pressure, underwhelming operational progress despite a strategic shift toward branded U.S. and European opportunities, and softer-than-expected recent results, although long-term confidence in management’s direction remains. Analyst Commentary Gross margin pressure negatively impacted Flora Growth's bottom line results this quarter.Analysis Article • Jul 11
Investors Aren't Buying Flora Growth Corp.'s (NASDAQ:FLGC) Revenues
Flora Growth Corp.'s ( NASDAQ:FLGC ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now...
New Narrative • Apr 17
US Cannabis And European Beverage Markets Will Create Opportunities
Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry.Analysis Article • Mar 27
Is Flora Growth (NASDAQ:FLGC) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Jan 30
Flora Growth Corp. (NASDAQ:FLGC) Might Not Be As Mispriced As It Looks After Plunging 25%
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 25% in the...Analysis Article • Dec 01
Flora Growth Corp.'s (NASDAQ:FLGC) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Flora Growth Corp. ( NASDAQ:FLGC ) shares have continued their recent momentum with a 28% gain in the last month alone...Analysis Article • Nov 20
Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysis Article • Sep 18
The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...Analysis Article • Aug 16
Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Today is shaping up negative for Flora Growth Corp. ( NASDAQ:FLGC ) shareholders, with the analysts delivering a...Analysis Article • May 22
Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 27% over the previous 30 days, handing...Analysis Article • Apr 04
Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...Analysis Article • Feb 17
Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 51% over the previous 30 days, handing...Analysis Article • Dec 22
The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shares have had a really impressive month, gaining 41% after a shaky period...Analysis Article • Apr 17
Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding
Flora Growth Corp. ( NASDAQ:FLGC ) shares have retraced a considerable 28% in the last month, reversing a fair amount...Analysis Article • Dec 08
News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders will have a reason to smile today, with the analysts making substantial...Shareholder Returns
| ZSTK | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -5.1% | 6.6% | -4.1% |
| 1Y | -84.7% | 18.5% | 20.6% |
Return vs Industry: ZSTK underperformed the US Healthcare industry which returned 20.6% over the past year.
Return vs Market: ZSTK underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| ZSTK volatility | |
|---|---|
| ZSTK Average Weekly Movement | 16.5% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ZSTK's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ZSTK's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 21 | Daniel Reis-Faria | zerostack.ai |
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants.
ZeroStack Corp. Fundamentals Summary
| ZSTK fundamental statistics | |
|---|---|
| Market cap | US$11.55m |
| Earnings (TTM) | -US$151.73m |
| Revenue (TTM) | US$36.08m |
0.3x
P/S Ratio-0.1x
P/E RatioIs ZSTK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZSTK income statement (TTM) | |
|---|---|
| Revenue | US$36.08m |
| Cost of Revenue | US$31.82m |
| Gross Profit | US$4.26m |
| Other Expenses | US$155.99m |
| Earnings | -US$151.73m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -62.42 |
| Gross Margin | 11.81% |
| Net Profit Margin | -420.49% |
| Debt/Equity Ratio | 8.6% |
How did ZSTK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/10 05:01 |
| End of Day Share Price | 2026/06/10 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ZeroStack Corp. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| William Kirk | Roth Capital Partners |